302 related articles for article (PubMed ID: 2840081)
1. Preferential inhibition of 5-lipoxygenase activity by manoalide.
De Vries GW; Amdahl L; Mobasser A; Wenzel M; Wheeler LA
Biochem Pharmacol; 1988 Aug; 37(15):2899-905. PubMed ID: 2840081
[TBL] [Abstract][Full Text] [Related]
2. Effect of manoalide on human 5-lipoxygenase activity.
Cabré F; Carabaza A; Suesa N; García AM; Rotllan E; Gómez M; Tost D; Mauleón D; Carganico G
Inflamm Res; 1996 May; 45(5):218-23. PubMed ID: 8737743
[TBL] [Abstract][Full Text] [Related]
3. 1-[4-[3-[4-[bis(4-fluorophenyl)hydroxymethyl]-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone(AHR-5333): a selective human blood neutrophil 5-lipoxygenase inhibitor.
Graff G; Anderson LA
Prostaglandins; 1989 Oct; 38(4):473-96. PubMed ID: 2554366
[TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivo.
Tateson JE; Randall RW; Reynolds CH; Jackson WP; Bhattacherjee P; Salmon JA; Garland LG
Br J Pharmacol; 1988 Jun; 94(2):528-39. PubMed ID: 2840160
[TBL] [Abstract][Full Text] [Related]
5. Exogenous action of 5-lipoxygenase by its metabolites on luteinizing hormone release in rat pituitary cells.
Przylipiak A; Kiesel L; Habenicht AJ; Przylipiak M; Runnebaum B
Mol Cell Endocrinol; 1990 Feb; 69(1):33-9. PubMed ID: 2157615
[TBL] [Abstract][Full Text] [Related]
6. Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models.
Carty TJ; Sweeney FJ; Griffiths RJ; Eskra JD; Ernest MJ; Pillar JS; Cheng JD; Loose LD; Joseph PA; Pazoles PP; Moore PF; Nagahisa A; Murase S; Kadin SB
Inflamm Res; 1997 May; 46(5):168-79. PubMed ID: 9197987
[TBL] [Abstract][Full Text] [Related]
7. SK&F 86002: a structurally novel anti-inflammatory agent that inhibits lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid.
Griswold DE; Marshall PJ; Webb EF; Godfrey R; Newton J; DiMartino MJ; Sarau HM; Gleason JG; Poste G; Hanna N
Biochem Pharmacol; 1987 Oct; 36(20):3463-70. PubMed ID: 2823821
[TBL] [Abstract][Full Text] [Related]
8. Phorbol myristate acetate and the calcium ionophore A23187 synergistically induce release of LTB4 by human neutrophils: involvement of protein kinase C activation in regulation of the 5-lipoxygenase pathway.
Liles WC; Meier KE; Henderson WR
J Immunol; 1987 May; 138(10):3396-402. PubMed ID: 3033073
[TBL] [Abstract][Full Text] [Related]
9. Auranofin stimulates LTA hydrolase and inhibits 5-lipoxygenase/LTA synthase activity of isolated human neutrophils.
Betts WH; Hurst NP; Murphy GA; Cleland LG
Biochem Pharmacol; 1990 Apr; 39(7):1233-7. PubMed ID: 2157444
[TBL] [Abstract][Full Text] [Related]
10. Studies on the release of leukotrienes and histamine by human lung parenchymal and bronchial fragments upon immunologic and nonimmunologic stimulation. Effects of nordihydroguaiaretic acid, aspirin, and sodium cromoglycate.
Salari H; Borgeat P; Fournier M; Hebert J; Pelletier G
J Exp Med; 1985 Dec; 162(6):1904-15. PubMed ID: 2415659
[TBL] [Abstract][Full Text] [Related]
11. Arachidonate lipoxygenase inhibitors in guinea-pig isolated trachea. Effects on contractions to antigen and various agonists.
Yamamoto A; Shikada K; Tanaka S
Prostaglandins; 1990 Dec; 40(6):615-25. PubMed ID: 1965555
[TBL] [Abstract][Full Text] [Related]
12. The effects of a novel series of selective inhibitors of arachidonate 5-lipoxygenase on anaphylactic and inflammatory responses.
Bhattacherjee P; Boughton-Smith NK; Follenfant RL; Garland LG; Higgs GA; Hodson HF; Islip PJ; Jackson WP; Moncada S; Payne AN
Ann N Y Acad Sci; 1988; 524():307-20. PubMed ID: 2837965
[TBL] [Abstract][Full Text] [Related]
13. Effects of the new 5-lipoxygenase inhibitor E6080 on leukotriene release in vitro.
Sakuma Y; Katayama S; Tsunoda H; Abe S; Yamatsu I; Katayama K
Int Arch Allergy Immunol; 1992; 97(4):267-73. PubMed ID: 1375926
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of leukotriene-induced contraction of guinea pig trachea by 5-lipoxygenase inhibitors.
Schwalm SF; Lewis AJ; Hand JM
Prostaglandins; 1987 Jan; 33(1):113-9. PubMed ID: 3108959
[TBL] [Abstract][Full Text] [Related]
15. Generation and metabolism of 5-lipoxygenase pathway leukotrienes by human eosinophils: predominant production of leukotriene C4.
Weller PF; Lee CW; Foster DW; Corey EJ; Austen KF; Lewis RA
Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7626-30. PubMed ID: 6324182
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of inhibitors of eicosanoid synthesis in leukocytes: possible pitfall of using the calcium ionophore A23187 to stimulate 5' lipoxygenase.
Salmon JA; Tilling LC; Moncada S
Prostaglandins; 1985 Mar; 29(3):377-85. PubMed ID: 2988019
[TBL] [Abstract][Full Text] [Related]
17. 1,4-Dihydronaphthoquinones, hydroindoloquinones, benzofurans, and benzothiophenes as inhibitors of 5-lipoxygenase. Synthesis and structure-activity studies.
Yamashita A; Schaub RG; Bach MK; White GJ; Toy A; Ghazal NB; Burdick MD; Brashler JR; Holm MS
J Med Chem; 1990 Feb; 33(2):775-81. PubMed ID: 2153828
[TBL] [Abstract][Full Text] [Related]
18. In vitro inhibition of leukotriene B4 formation by exogeneous 5-lipoxygenase inhibitors is associated with enhanced generation of 15-hydroxy-eicosatetraenoic acid (15-HETE) by human neutrophils.
Fogh K; Herlin T; Kragballe K
Arch Dermatol Res; 1988; 280(7):430-6. PubMed ID: 2849922
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of leukotriene C4 and B4 generation by human eosinophils and neutrophils with the lipoxygenase pathway inhibitors U60257 and BW755C.
Cromwell O; Shaw RJ; Walsh GM; Mallet AI; Kay AB
Int J Immunopharmacol; 1985; 7(5):775-81. PubMed ID: 2995265
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of bovine lymphocyte response to phytohemagglutinin by a specific 5-lipoxygenase inhibitor.
Atluru D; Sayana U; Yang WC; Schultz RD
Vet Immunol Immunopathol; 1987 Mar; 14(3):269-78. PubMed ID: 3035781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
